Hello, and welcome back to The Kable where we're ringing in the weekend. This has been a week and a half so far and Friday isn't showing signs of letting up either.
In some hair-raising news, India's Sun Pharma is plonking down $576 million (plus milestones) to acquire Concert Pharmaceuticals, betting on its late-stage treatment for alopecia.
In more news…
💉 Gavi's new innovation accelerator; Senegal gets CEPI's millions; A new herbal cure for cancer
#259 | Sun Pharma conducts a big buy; Intas Pharma sends documents to die; Oyster mushrooms are killer fungi
